U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C11H9NO4
Molecular Weight 219.1935
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of NIVIMEDONE

SMILES

CC1=C(C)C=C2C(O)=C(C(=O)C2=C1)[N+]([O-])=O

InChI

InChIKey=JXGBXHHEYIRNGA-UHFFFAOYSA-N
InChI=1S/C11H9NO4/c1-5-3-7-8(4-6(5)2)11(14)9(10(7)13)12(15)16/h3-4,13H,1-2H3

HIDE SMILES / InChI

Molecular Formula C11H9NO4
Molecular Weight 219.1935
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Sodium nivimedone (BRL10833) is an orally administered anti-allergic agent with similar properties to DSCG. Nivimedone inhibited IgE-mediated passive cutaneous anaphylactic (PCA) reactions in the rat and the antigen-induced release of histamine from human lung passively sensitized with atopic serum. The pharmacological potency of sodium nivimedone when compared to DSCG was 42 times greater in the human lung system and approximately ten times greater in rat PCA. In addition, single doses of sodium nivimedone given by mouth inhibited antigen-induced bronchoconstriction in man.

Approval Year

PubMed

PubMed

TitleDatePubMed
Peritoneal anaphylaxis in the rat after sensitization with mouse antiserum.
1978
The orally administered anti-allergic agent, sodium nivimedone (BRL 10833); efficacy in bronchial asthma and effects on IgE, complement and eosinophils.
1979 Jul

Sample Use Guides

In Vivo Use Guide
Sodium nivimedone (BRL10833) given at an oral dose of 200 mg thrice daily, was compared, after a preliminary standardization week, with placebo in a 6-week double-blind cross-over trial.
Route of Administration: Oral
In Vitro Use Guide
Nivimedone (BRL10833) increases cAMP at a relatively high dose (10(-4) M) in guinea pig ileum.
Substance Class Chemical
Created
by admin
on Fri Dec 15 16:38:35 GMT 2023
Edited
by admin
on Fri Dec 15 16:38:35 GMT 2023
Record UNII
1M887244YI
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
NIVIMEDONE
INN  
INN  
Official Name English
nivimedone [INN]
Common Name English
1H-INDENE-1,3(2H)-DIONE, 5,6-DIMETHYL-2-NITRO-, ION(1-)
Common Name English
5,6-DIMETHYL-2-ACI-NITRO-1,3-INDANDIONE
Systematic Name English
Classification Tree Code System Code
NCI_THESAURUS C29714
Created by admin on Fri Dec 15 16:38:35 GMT 2023 , Edited by admin on Fri Dec 15 16:38:35 GMT 2023
Code System Code Type Description
MESH
C012136
Created by admin on Fri Dec 15 16:38:35 GMT 2023 , Edited by admin on Fri Dec 15 16:38:35 GMT 2023
PRIMARY
PUBCHEM
76966940
Created by admin on Fri Dec 15 16:38:35 GMT 2023 , Edited by admin on Fri Dec 15 16:38:35 GMT 2023
PRIMARY
EVMPD
SUB09333MIG
Created by admin on Fri Dec 15 16:38:35 GMT 2023 , Edited by admin on Fri Dec 15 16:38:35 GMT 2023
PRIMARY
FDA UNII
1M887244YI
Created by admin on Fri Dec 15 16:38:35 GMT 2023 , Edited by admin on Fri Dec 15 16:38:35 GMT 2023
PRIMARY
CAS
49561-92-4
Created by admin on Fri Dec 15 16:38:35 GMT 2023 , Edited by admin on Fri Dec 15 16:38:35 GMT 2023
PRIMARY
EPA CompTox
DTXSID80197841
Created by admin on Fri Dec 15 16:38:35 GMT 2023 , Edited by admin on Fri Dec 15 16:38:35 GMT 2023
PRIMARY
INN
4114
Created by admin on Fri Dec 15 16:38:35 GMT 2023 , Edited by admin on Fri Dec 15 16:38:35 GMT 2023
PRIMARY
NCI_THESAURUS
C84021
Created by admin on Fri Dec 15 16:38:35 GMT 2023 , Edited by admin on Fri Dec 15 16:38:35 GMT 2023
PRIMARY
CAS
838868-56-7
Created by admin on Fri Dec 15 16:38:35 GMT 2023 , Edited by admin on Fri Dec 15 16:38:35 GMT 2023
ALTERNATIVE
SMS_ID
100000084125
Created by admin on Fri Dec 15 16:38:35 GMT 2023 , Edited by admin on Fri Dec 15 16:38:35 GMT 2023
PRIMARY
Related Record Type Details
ACTIVE MOIETY